Differences in the Serum 4β-hydroxycholesterol Levels of Patients with Chronic Hepatitis C Virus (HCV) Infection: A Possible Impact on the Efficacy and Safety of Interferon (IFN)-free Treatment-Reference-Cited by-同舟云学术

Differences in the Serum 4β-hydroxycholesterol Levels of Patients with Chronic Hepatitis C Virus (HCV) Infection: A Possible Impact on the Efficacy and Safety of Interferon (IFN)-free Treatment

Published:2018-05-01 Issue:9 Volume:57 Page:1219-1227
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Hirayama Takeshi¹,Ikegami Tadashi¹,Honda Akira¹²,Miyazaki Teruo²,Yara Sho-Ichiro¹,Kohjima Motoyuki³,Nakamuta Makoto⁴,Matsuzaki Yasushi¹

Affiliation:

1. Division of Gastroenterology and Hepatology, Tokyo Medical University Ibaraki Medical Center, Japan

2. Joint Research Center, Tokyo Medical University Ibaraki Medical Center, Japan

3. Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Japan

4. Department of Gastroenterology, National Hospital Organization Kyushu Medical Center, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/57/9/57_9479-17/_pdf

Reference25 articles.

1. 1. Suzuki Y, Ikeda K, Suzuki F, et al. Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options. J Hepatol 58: 655-662, 2013.

2. 2. Kumada H, Suzuki Y, Ikeda K, et al. Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection. Hepatology 59: 2083-2091, 2014.

3. 3. Karino Y, Toyota J, Ikeda K, et al. Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir. J Hepatol 58: 646-654, 2013.

4. 4. Asahina Y, Izumi N, Hiromitsu K, et al. JSH Guidlines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2. Hepatol Res 46: 129-165, 2016.

5. 5. Bodin K, Bretillon L, Aden Y, et al. Antiepileptic drugs increase plasma levels of 4beta-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4. J Biol Chem 276: 38685-38689, 2001.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Approaches to Characterize Individual Drug Metabolism and Advance Precision Medicine;Drug Metabolism and Disposition;2023-07-07

2. Sensitive UHPLC-MS/MS quantification method for 4β- and 4α-hydroxycholesterol in plasma for accurate CYP3A phenotyping;Journal of Lipid Research;2022-03

3. New Function of Cholesterol Oxidation Products Involved in Osteoporosis Pathogenesis;International Journal of Molecular Sciences;2022-02-11